Tandem Diabetes Care Inc. | Small-cap | Healthcare
$11.93
7.92%
| Tandem Diabetes Care Stock Comparison:
Tandem Diabetes Care vs Abbott LaboratoriesTandem Diabetes Care vs Boston ScientificTandem Diabetes Care vs QuidelOrthoTandem Diabetes Care vs EnovisTandem Diabetes Care vs ConmedTandem Diabetes Care vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 234.4M
Gross Profit 118.4M 50.51%
Operating Income -120.9M -51.56%
Net Income -130.6M -55.69%
EPS (Diluted) $-1.97

Balance Sheet Metrics

Total Assets 922.1M
Total Liabilities 766.9M
Shareholders Equity 155.3M
Debt to Equity 4.94

Cash Flow Metrics

Operating Cash Flow -6.7M
Free Cash Flow -15.7M

Revenue & Profitability Trend

Tandem Diabetes Care Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i940.2M747.7M801.2M702.8M498.8M
Cost of Goods Sold i450.6M380.0M388.2M326.6M238.3M
Gross Profit i489.6M367.7M413.0M376.2M260.5M
Gross Margin % i52.1%49.2%51.5%53.5%52.2%
Operating Expenses
Research & Development i198.9M169.7M139.1M92.1M63.6M
Selling, General & Administrative i389.8M352.5M335.7M261.5M204.9M
Other Operating Expenses i-----
Total Operating Expenses i588.7M522.2M474.8M353.6M268.5M
Operating Income i-99.1M-154.5M-61.8M22.7M-8.0M
Operating Margin % i-10.5%-20.7%-7.7%3.2%-1.6%
Non-Operating Items
Interest Income i18.0M22.9M6.1M674.0K1.6M
Interest Expense i5.5M7.6M4.3M4.3M12.2M
Other Non-Operating Income-3.3M-78.8M-30.9M-1.4M-17.1M
Pre-tax Income i-91.9M-220.3M-92.9M15.9M-36.3M
Income Tax i4.2M2.4M1.7M335.0K-1.9M
Effective Tax Rate % i0.0%0.0%0.0%2.1%0.0%
Net Income i-96.0M-222.6M-94.6M15.6M-34.4M
Net Margin % i-10.2%-29.8%-11.8%2.2%-6.9%
Key Metrics
EBITDA i-68.5M-118.2M-43.3M35.4M3.4M
EPS (Basic) i$-1.47$-3.43$-1.47$0.25$-0.56
EPS (Diluted) i$-1.47$-3.43$-1.47$0.24$-0.56
Basic Shares Outstanding i6545100064969000641460006300000060990000
Diluted Shares Outstanding i6545100064969000641460006300000060990000

Income Statement Trend

Tandem Diabetes Care Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i69.2M58.9M172.5M71.2M94.6M
Short-term Investments i369.1M409.0M444.4M552.6M390.3M
Accounts Receivable i114.6M105.6M114.7M110.7M82.2M
Inventory i149.6M157.9M111.1M68.6M63.7M
Other Current Assets22.0M16.6M7.2M8.4M6.4M
Total Current Assets i724.5M748.0M850.0M811.5M637.2M
Non-Current Assets
Property, Plant & Equipment i82.2M69.6M62.8M52.8M44.0M
Goodwill i925.0K2.8M4.6M6.6M8.8M
Intangible Assets i925.0K2.8M4.6M6.6M8.8M
Long-term Investments-----
Other Non-Current Assets4.2M37.6M19.0M9.1M580.0K
Total Non-Current Assets i243.2M204.7M202.8M93.6M79.2M
Total Assets i967.7M952.7M1.1B905.1M716.4M
Liabilities
Current Liabilities
Accounts Payable i44.7M49.6M55.7M28.0M17.8M
Short-term Debt i58.9M17.1M13.1M9.3M9.4M
Current Portion of Long-term Debt-----
Other Current Liabilities49.3M28.5M29.3M23.4M31.6M
Total Current Liabilities i247.0M195.3M165.3M131.9M103.9M
Non-Current Liabilities
Long-term Debt i414.7M398.6M406.8M305.4M218.9M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities32.4M31.8M23.9M17.8M27.4M
Total Non-Current Liabilities i457.5M443.8M447.5M340.2M246.3M
Total Liabilities i704.6M639.0M612.8M472.0M350.1M
Equity
Common Stock i66.0K66.0K65.0K64.0K62.0K
Retained Earnings i-1.0B-951.8M-729.2M-634.6M-659.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i263.1M313.6M439.9M433.1M366.3M
Key Metrics
Total Debt i473.6M415.7M419.9M314.7M228.3M
Working Capital i477.4M552.7M684.7M679.7M533.4M

Balance Sheet Composition

Tandem Diabetes Care Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-96.0M-222.6M-94.6M15.6M-34.4M
Depreciation & Amortization i16.6M15.7M14.3M13.8M10.5M
Stock-Based Compensation i101.4M88.1M84.9M60.8M58.4M
Working Capital Changes i-9.4M-11.1M-4.1M11.3M-30.9M
Operating Cash Flow i15.7M-34.3M42.0M105.6M11.6M
Investing Activities
Capital Expenditures i-19.2M-26.8M-34.1M-14.2M-27.4M
Acquisitions i0-69.5M-25.7M0-
Investment Purchases i-310.7M-510.9M-467.7M-733.4M-497.1M
Investment Sales i306.5M546.2M569.5M570.0M233.3M
Investing Cash Flow i-23.5M-60.9M42.0M-177.5M-291.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i306.8M-00278.7M
Debt Repayment i-246.1M-000
Financing Cash Flow i45.1M-71.0K-675.0K0244.6M
Free Cash Flow i5.0M-83.4M7.5M87.8M-7.6M
Net Change in Cash i37.3M-95.3M83.4M-72.0M-34.9M

Cash Flow Trend

Tandem Diabetes Care Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -7.27
Forward P/E -9.00
Price to Book 5.52
Price to Sales 0.73
PEG Ratio -0.11

Profitability Ratios

Profit Margin -20.51%
Operating Margin -13.24%
Return on Equity -111.92%
Return on Assets -6.41%

Financial Health

Current Ratio 2.44
Debt to Equity 340.56
Beta 1.47

Per Share Data

EPS (TTM) $-3.08
Book Value per Share $1.97
Revenue per Share $15.12

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
tndm735.8M-7.275.52-111.92%-20.51%340.56
Abbott Laboratories 229.3B16.534.5330.93%32.43%26.50
Boston Scientific 153.7B61.766.8511.55%13.55%53.09
QuidelOrtho 1.8B-0.860.64-15.64%-17.01%100.33
Enovis 1.7B-2.040.66-28.25%-37.80%56.75
Conmed 1.7B15.401.6811.69%8.31%87.93

Financial data is updated regularly. All figures are in the company's reporting currency.